Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19

• Main Authors: Si-Hyuck Kang (Author), Dong-Hoon Lee (Author), Kyung-Do Han (Author), Jin-Hyung Jung (Author), Sang-Hyun Park (Author), Andrew M. Dai (Author), Henry G. Wei (Author), Chang-Hwan Yoon (Author), Tae-Jin Youn (Author), In-Ho Chae (Author), Cheol-Ho Kim (Author)
• Format: Book
• Published: BMC, 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background There have been concerns regarding the safety of renin-angiotensin-aldosterone-system (RAAS)-blocking agents including angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) during the coronavirus disease 2019 (COVID-19) pandemic. This study sough...